Beta 2-Microglobulin Apheresis Column
The Beta 2-Microglobulin Apheresis Column is an extracorporeal blood treatment device used to provide relief of symptoms of clinically diagnosed dialysis-related amyloidosis (DRA) by selectively removing beta 2-microglobulin from the patient's blood during dialysis. The device carries a class of "f," indicating a special or biological regulatory pathway, with no assigned regulation number or standard medical specialty. It was reviewed by an unspecified panel. It is not an implant and is not life-sustaining.
Research product code PDI in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- PDI
- Medical Specialty
- Unknown
- Review Panel
- GU
- Submission Type
- 6
Device Characteristics
Definition
Relief of symptoms of clinically diagnosed dialysis-related amyloidosis (DRA).
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.